# Comprehensive autonomic nervous system evaluation in stroke patients: heart rate variability as a cornerstone for recovery prediction

## TL;DR

Heart rate variability (HRV) is a key indicator for predicting stroke recovery, and combining it with other measures like blood pressure and pupil response improves accuracy.

## Contribution

This paper synthesizes recent evidence on multimodal autonomic nervous system assessment in stroke patients, emphasizing HRV as a cornerstone for prognosis.

## Key findings

- Time-domain HRV metrics like SDNN and RMSSD predict post-stroke outcomes and complications.
- Combining HRV with blood pressure variability and pupillometry improves short-term and long-term prognosis accuracy.
- Consumer-grade wearables show high agreement with ECG standards for HRV monitoring.

## Abstract

Autonomic nervous system (ANS) dysfunction significantly impacts stroke outcomes, yet standardized autonomic monitoring remains underutilized in clinical practice. Recent evidence highlights heart rate variability (HRV) as a robust prognostic marker, while complementary modalities like blood pressure variability (BPV) and pupillometry enhance risk stratification.

To synthesize current evidence on multimodal ANS assessment in stroke patients, with HRV as the cornerstone biomarker, and provide practical recommendations for clinical implementation.

We conducted a narrative review of peer-reviewed studies (2018–2024) from major databases, focusing on HRV and complementary ANS modalities in stroke patients. The analysis included 53 studies from diverse global regions, with a specific focus on technology-enabled investigations and prospective cohorts that emerged from 2022 to 2024.

Time-domain HRV metrics such as SDNN (standard deviation of all normal-to-normal RR intervals) and RMSSD (root mean square of successive differences) consistently predicted functional outcomes and cardiovascular complications post-stroke. Beat-to-beat blood pressure variability (BPV) within the first 24 h post-ischemic stroke outperforms HRV alone for short-term prognosis, with an AUC improvement of 10–15%. Nocturnal HRV combined with BPV and endothelial function enhanced prediction of recurrent cerebrovascular events. Automated pupillometry, with Neurological Pupil index (NPi < 3), predicts post-stroke delirium; integration with HRV metrics improves prognostic accuracy. Consumer-grade wearables demonstrated high agreement with ECG standards, enabling scalable remote monitoring.

HRV-centered multimodal ANS assessment offers robust, non-invasive prognostic tools for stroke management. Integration with BPV, pupillometry, and wearable technology enhances risk stratification across acute and rehabilitation phases. Standardized protocols and technology adoption could transform stroke outcomes globally, particularly in resource-limited settings.